Health Catalyst, Inc. (HCAT) research
Health Catalyst, Inc.- Sector
- Healthcare
- Industry
- Health Information Services
- Last price
- $1.89
- As of
Health Catalyst, Inc. (HCAT): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-14.
As of . Source: SEC EDGAR filings for HCAT. Method and limitations.
Share the HCAT intelligence card
See HCAT live in the terminal
Track HCAT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live HCAT terminal, freeActive signals for HCAT
- highCONSENSUS_BUY
3 tracked funds increased HCAT this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 52% of HCAT (2026Q2)
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +61% to HCAT (2026Q2)
- mediumNEW_POSITION
CITADEL ADVISORS LLC new position in HCAT
- mediumNEW_POSITION
CITADEL ADVISORS LLC new position in HCAT
FREE, NO ACCOUNT
Every signal on HCAT, as it fires
You are seeing 5 of 25 signals recorded on HCAT since 2026-05-24.
The five above landed across 2 days. The other 20 were recorded on 2 other days. 21 of the 25 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in HCAT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 42225T107 · 2026Q2 | $1M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 42225T107 · 2026Q2 | $902K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 42225T107 · 2026Q2 | $695K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 42225T107 · 2026Q2 | $27K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, HCAT
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
HCAT against its peers
HCAT's operating margin of -51.7% ranks in the 31st percentile of 17 Health Information Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-01-31.
| Metric | HCAT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 311M USD | 109M USD | 86 | 17 |
| Gross margin | n/a | 67.3% | n/a | 11 |
| Operating margin | -51.7% | -7.1% | 31 | 17 |
| Net margin | -57.2% | -11.7% | 31 | 17 |
| Return on equity | -72.4% | -15.6% | 25 | 17 |
| P / E | n/a | 21.5x | n/a | 7 |
Peers (19): OPRX, LFMD, CCLD, RVRC, AMWL, SY, DRIO, VASO, TBRG, CARL, NRC, ONMD, WEAV, PHR, SOPH, CRVW, BEAT, PBSV, HCTI. Left out: HYDTF (no annual filing), RNLXY (period gap), DGNOF (no annual filing), VRHI (no annual filing), RMHI (no annual filing), OHCFF (no annual filing). Fiscal periods ending between 2025-10-31 and 2026-01-31. Every figure is one full fiscal year read from one annual filing (HCAT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more HCAT signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to HCATand get the insider, 13F, options, and confluence read in one view.